Immunotherapies are promising as a holy grail for cancer treatment, but patient actions to these interventions are typically variable in both solid growths and blood cancers. In this episode, Iris Kulbatski from The Scientists Creative Services Team talked with Olli Dufva, a physician and doctoral scientist at the University of Helsinkis Hematology Research Unit, about his work examining the genomic landscape of hematological cancers. Coupling next-generation techniques with traditional methods such as flow cytometry, he aims to much better comprehend the intricate series of immune qualities in different cancer subtypes and utilize that data to forecast patient outcomes.LabTalk is a scandal sheet podcast produced by The Scientists Creative Services Team, where we check out subjects at the leading edge of ingenious research study. This months episode is sponsored by Sartorius.SpeakerOlli Dufva, MDPhysician and Doctoral ResearcherHematology Research Unit HelsinkiTranslational Immunology Research ProgramUniversity of Helsinki ____________________________________________________________________ The Sartorius Group is a prominent worldwide partner of biopharmaceutical research and the market. With innovative laboratory instruments and consumables, the Groups Lab Products & & Services Division focuses on serving the needs of laboratories carrying out research study and quality control at pharma and biopharma companies and those of academic research study institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use options assists customers to produce biotech medications and vaccines securely and efficiently.Sponsored by
